Hereditary leiomyomatosis and renal cell cancer (HLRCC)

Maija Ht Kiuru, Virpi Launonen

Research output: Contribution to journalReview article

46 Citations (Scopus)

Abstract

Hereditary leiomyomatosis and renal cell cancer (HLRCC) (MIM 605839) is a recently identified autosomal dominant tumor susceptibility syndrome characterized by predisposition to benign leiomyomas of the skin and the uterus (fibroids, myomas). Susceptibility to early-onset renal cell carcinoma and uterine leiomyosarcoma is present in a subset of families. Renal cell carcinomas are typically solitary and aggressive tumors displaying papillary type 2 or collecting duct histology. The disease predisposing gene was identified as fumarate hydratase (fumarase, FH) (MIM 136850). FH encodes an enzyme that operates in the mitochondrial Krebs cycle being thus involved in cellular energy metabolism. The recent discovery of HLRCC and the predisposing gene FH has increased the present knowledge of hereditary renal cancer and enabled identification of the predisposed individuals. This review provides the present knowledge of the clinical, histopathological, and molecular features of HLRCC. Future prospects related to studies on the phenotype and molecular biology of HLRCC will also be discussed.

Original languageEnglish (US)
Pages (from-to)869-875
Number of pages7
JournalCurrent Molecular Medicine
Volume4
Issue number8
DOIs
StatePublished - Dec 2004
Externally publishedYes

Fingerprint

Fumarate Hydratase
Tumors
Genes
Cells
Molecular biology
Histology
Leiomyoma
Renal Cell Carcinoma
Ducts
Skin
Myoma
Citric Acid Cycle
Leiomyosarcoma
Kidney Neoplasms
Neoplasm Genes
Enzymes
Energy Metabolism
Molecular Biology
Neoplasms
Phenotype

Keywords

  • FH
  • Fumarase
  • HLRCC
  • Leiomyoma
  • Leiomyosarcoma
  • Renal cancer

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology

Cite this

Hereditary leiomyomatosis and renal cell cancer (HLRCC). / Kiuru, Maija Ht; Launonen, Virpi.

In: Current Molecular Medicine, Vol. 4, No. 8, 12.2004, p. 869-875.

Research output: Contribution to journalReview article

Kiuru, Maija Ht ; Launonen, Virpi. / Hereditary leiomyomatosis and renal cell cancer (HLRCC). In: Current Molecular Medicine. 2004 ; Vol. 4, No. 8. pp. 869-875.
@article{0243e64ce1df4016bcd8a12b3d505e5b,
title = "Hereditary leiomyomatosis and renal cell cancer (HLRCC)",
abstract = "Hereditary leiomyomatosis and renal cell cancer (HLRCC) (MIM 605839) is a recently identified autosomal dominant tumor susceptibility syndrome characterized by predisposition to benign leiomyomas of the skin and the uterus (fibroids, myomas). Susceptibility to early-onset renal cell carcinoma and uterine leiomyosarcoma is present in a subset of families. Renal cell carcinomas are typically solitary and aggressive tumors displaying papillary type 2 or collecting duct histology. The disease predisposing gene was identified as fumarate hydratase (fumarase, FH) (MIM 136850). FH encodes an enzyme that operates in the mitochondrial Krebs cycle being thus involved in cellular energy metabolism. The recent discovery of HLRCC and the predisposing gene FH has increased the present knowledge of hereditary renal cancer and enabled identification of the predisposed individuals. This review provides the present knowledge of the clinical, histopathological, and molecular features of HLRCC. Future prospects related to studies on the phenotype and molecular biology of HLRCC will also be discussed.",
keywords = "FH, Fumarase, HLRCC, Leiomyoma, Leiomyosarcoma, Renal cancer",
author = "Kiuru, {Maija Ht} and Virpi Launonen",
year = "2004",
month = "12",
doi = "10.2174/1566524043359638",
language = "English (US)",
volume = "4",
pages = "869--875",
journal = "Current Molecular Medicine",
issn = "1566-5240",
publisher = "Bentham Science Publishers B.V.",
number = "8",

}

TY - JOUR

T1 - Hereditary leiomyomatosis and renal cell cancer (HLRCC)

AU - Kiuru, Maija Ht

AU - Launonen, Virpi

PY - 2004/12

Y1 - 2004/12

N2 - Hereditary leiomyomatosis and renal cell cancer (HLRCC) (MIM 605839) is a recently identified autosomal dominant tumor susceptibility syndrome characterized by predisposition to benign leiomyomas of the skin and the uterus (fibroids, myomas). Susceptibility to early-onset renal cell carcinoma and uterine leiomyosarcoma is present in a subset of families. Renal cell carcinomas are typically solitary and aggressive tumors displaying papillary type 2 or collecting duct histology. The disease predisposing gene was identified as fumarate hydratase (fumarase, FH) (MIM 136850). FH encodes an enzyme that operates in the mitochondrial Krebs cycle being thus involved in cellular energy metabolism. The recent discovery of HLRCC and the predisposing gene FH has increased the present knowledge of hereditary renal cancer and enabled identification of the predisposed individuals. This review provides the present knowledge of the clinical, histopathological, and molecular features of HLRCC. Future prospects related to studies on the phenotype and molecular biology of HLRCC will also be discussed.

AB - Hereditary leiomyomatosis and renal cell cancer (HLRCC) (MIM 605839) is a recently identified autosomal dominant tumor susceptibility syndrome characterized by predisposition to benign leiomyomas of the skin and the uterus (fibroids, myomas). Susceptibility to early-onset renal cell carcinoma and uterine leiomyosarcoma is present in a subset of families. Renal cell carcinomas are typically solitary and aggressive tumors displaying papillary type 2 or collecting duct histology. The disease predisposing gene was identified as fumarate hydratase (fumarase, FH) (MIM 136850). FH encodes an enzyme that operates in the mitochondrial Krebs cycle being thus involved in cellular energy metabolism. The recent discovery of HLRCC and the predisposing gene FH has increased the present knowledge of hereditary renal cancer and enabled identification of the predisposed individuals. This review provides the present knowledge of the clinical, histopathological, and molecular features of HLRCC. Future prospects related to studies on the phenotype and molecular biology of HLRCC will also be discussed.

KW - FH

KW - Fumarase

KW - HLRCC

KW - Leiomyoma

KW - Leiomyosarcoma

KW - Renal cancer

UR - http://www.scopus.com/inward/record.url?scp=9744276042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9744276042&partnerID=8YFLogxK

U2 - 10.2174/1566524043359638

DO - 10.2174/1566524043359638

M3 - Review article

C2 - 15579034

AN - SCOPUS:9744276042

VL - 4

SP - 869

EP - 875

JO - Current Molecular Medicine

JF - Current Molecular Medicine

SN - 1566-5240

IS - 8

ER -